Intermittent reduced-dose methotrexate enabled continuation of induction therapy despite severe delayed methotrexate elimination in primary central nervous system lymphoma: a case report

Journal of Medical Case Reports · Published 2026-08-11 · Journal article · DOI 10.1186/s13256-026-06506-w

Free full text

Authors (5)

Ryotaro Imai, Dai Kamamoto, Masateru Katayama, Sadao Suga, Hikaru Sasaki

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Imai, R., Kamamoto, D., Katayama, M., et al. (2026). Intermittent reduced-dose methotrexate enabled continuation of induction therapy despite severe delayed methotrexate elimination in primary central nervous system lymphoma: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/s13256-026-06506-w

Related articles